Anna V. Gaponova - Concepedia

Author

Anna V. Gaponova

Fox Chase Cancer Center

Also Known As

A. Gaponova, A. V Gaponova, A. V. Gaponova, Anna Gaponova, Anna V. Gaponova, Gaponova, Anna

Publications

392

Citations

H-Index

Concepts

All Affiliations

Fox Chase Cancer Center Drexel University Kazan Federal University Moscow Institute of Physics and Technology Synta Pharmaceuticals (United States)

About

Anna V. Gaponova is an author at Fox Chase Cancer Center specializing in cell biology, medicine, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	67
2	Cell Biology	3	3	67
3	Natural Sciences	1	1	19
4	Cellular Physiology	1	1	36
5	Molecular Biology	1	1	19

Anna V. Gaponova

Publications

214

Citations

H-Index

Page 1

	Year	Citations
Ganetespib limits ciliation and cystogenesis in autosomal‐dominant polycystic kidney disease (ADPKD) Anna S. Nikonova, Alexander Y. Deneka, Anna A. Kiseleva, The FASEB Journal	2018	36
Lysosomal cystine export regulates mTORC1 signaling to guide kidney epithelial cell fate specialization Marine Berquez, Zhiyong Chen, Beatrice Paola Festa, Nature Communications Cystine StorageRapamycin Complex 1Cellular PhysiologyLysosomal Cystine ExportAutophagy	2023	36
Epithelial–mesenchymal transition: role in cancer progression and the perspectives of antitumor treatment Anna V. Gaponova, Sergey Rodin, A. A. Mazina, Acta Naturae	2020	34
A Novel HSP90 Inhibitor–Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer Anna V. Gaponova, Anna S. Nikonova, Alexander Y. Deneka, Clinical Cancer Research	2016	32
<i>Nedd9</i> Restrains Autophagy to Limit Growth of Early Stage Non–Small Cell Lung Cancer Alexander Y. Deneka, Meghan C. Kopp, Anna S. Nikonova, Cancer Research	2021	24
Successful CRISPR/Cas9 mediated homologous recombination in a chicken cell line Ekaterina Antonova, Olga Glazova, Anna V. Gaponova, F1000Research Transcriptional RegulationOff-target EffectFunctional GenomicsCrispr/cas9 SystemSuccessful Crispr/cas9	2018	19
Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model Alexander Y. Deneka, Leora Haber, Meghan C. Kopp, PLoS ONE Early Stage NsclcCancer BiologyTumor-targeted Sn38Tumor BiologyNsclc Mortality	2017	12
Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin Anna V. Gaponova, Alexander Y. Deneka, Tim N. Beck, Oncotarget	2016	11
Utilizing AI for the Identification and Validation of Novel Therapeutic Targets and Repurposed Drugs for Endometriosis Bonnie Hei Man Liu, Yuezhen Lin, Xi Long, Advanced Science	2024	10

Page 1